This is a preview of subscription content, log in via an institution to check access.
References
Hruska KA, Teitelbaum SL (1995) Renal osteodystrophy. N Engl J Med 333: 166–174
Portale AA, Booth BE, Halloran BP, Morris RC Jr (1984) Effect of dietary phosphorus on circulating concentrations of 1,25 dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 73: 1580–1589
Silver J, Russell J, Sherwood LM (1985) Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sei USA 82: 4270–4273
Slatopolsky E, Caglar S, Peneil JP, Taggart DD, Canterbury JM, Reiss E, Bricker NS (1971) On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest 50: 492–499
Lopez-Hilker S, Dusso AS, Rapp NS, Martin KJ, Slatopolsky E (1990) Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol, F432–F437
Clayton BE, Jenkins P, Round JM (1980) Paediatric chemical pathology. Blackwell, Oxford
Tamanaha K, Mak RHK, Rigden SPA, Turner C, Start KM, Haycock GB, Chantier C (1987) Long term suppression of hyperparathyroidism by phosphate binders in uremic children. Pediatr Nephrol 1: 145–149
Brown EM, Wilson RE, Eastman RC, Pallotta J, Marynick S (1982) Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure. J Clin Endocrinol Metab 84: 172–179
Ledermann SE, Johnson A, Dillon MJ, Trompeter RS, Barrett TM (1994) Serum intact parathyroid hormone and ionised calcium concentration in children with renal insufficiency. Pediatr Nephrol 8: 561–565
Wou PCS, Lima E, Turner C, Rigden S, Buckland-Wright JC (1993) Short communication: quantitative macroradiography with biochemical correlation of children with renal osteodystrophy. Br J Radiol 66: 743–747
Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB (1994) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46: 1160–1166
Owen TA, Aronour MS, Barone LM, Bettencourt B, Stein GS, Lian LB (1991) Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128: 1496–1504
Morin D, Turner C, Rigden SPA (1993) Effective control of phosphate and PTH by calcium carbonate and daily oral low dose 1 alpha hydroxycholecalciferol in children on peritoneal dialysis. Perit Dial Int 13: S56
Mak RHK, Turner C, Thompson T, Powell H, Haycock GB, Chantier C (1985) Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide. BMJ 291: 623–627
Hamdy NAT, Kanis JA, Beneton MNC, Brown CB, Juttman JR, Jordans JGM, Josse S, Meyrier A, Lins RL, Fairey IT (1995) Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 310: 358–363
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rigden, S.P.A. The treatment of renal osteodystrophy. Pediatr Nephrol 10, 653–655 (1996). https://doi.org/10.1007/s004670050184
Issue Date:
DOI: https://doi.org/10.1007/s004670050184